Write a reviewFor vendors
♡
Home / Investors / Bali Muralidhar

Bali Muralidhar

Venture Fund · London

About Bali Muralidhar

Venture capital investor (Global Head of Life Sciences) based in London, United Kingdom. Focus areas include Health Care, Autoimmune Diseases, Wellness. Invests at series b stage. Past investments include Kesios Therapeutics, Spruce Biosciences, Amarin.

Investment focus

Stages
Series B
Sectors
Health CareAutoimmune DiseasesWellnessWomen FoundedFundraisingInvestment ManagementStrategic PartnershipsLife SciencePortfolio ManagementFinanceBiotechnologyDrug DevelopmentElectronic Health Records (EHR)Health and Hospital ServicesClinical TrialsGene TherapyVaccinesUK-based StartupsRegulatory ComplianceMedical

Portfolio

No portfolio companies recorded yet; Bali Muralidhar reports 60 investments overall.

Similar investors

Aakash Tulsani

Venture Fund · Singapore
Series BHealth CareHospitalsE-commerceSports+16
60Investments
—Exits

Aaref Hilaly

Angel Investor · San Francisco
SeedSeries BEarly Stage VentureSeries AHealth CareData IntegrationTalent ManagementE-commerce+16
60Investments
—Exits

Aaron Goldman

Venture Fund · New York City
Series BHealth CareTalent ManagementE-commerceWellness+16
60Investments
—Exits

Adam Goulburn

Venture Fund · New York City
Series BHealth CareRegenerative MedicineDrug DiscoveryData Science+16
60Investments
—Exits

Adam Greene

Venture Fund · New York City
Series BHealth CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)+14
60Investments
—Exits

Adam Margolin

Venture Fund · Boston
Series BAdvertisingHealth CareWearablesE-commerce+16
60Investments
—Exits